ARTICLE | Management Tracks
Lee joins Lycia as CMO
Plus: Firth joins Panacea, Lakewood appoints Manion chair and updates from Ai Proteins, Cognito and Kala
February 13, 2025 1:38 AM UTC
Lycia Therapeutics Inc., which is developing protein degraders that target the lysosomes, hired Chin Lee as CMO. Lee was CMO of Allakos Inc. (NASDAQ:ALLK). Lycia also unveiled a pair of programs targeting indications in IgE-mediated disease and Graves’ disease.
Carl Firth has become a partner at Panacea Venture. Firth, who is based in Singapore but will have a global role for the firm, founded and was CEO of Aslan Pharmaceuticals Ltd...